カテゴリー： 世界, 部品/材料, QYResearch

イオパミドールAPIの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Iopamidol API Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX01301）・商品コード：QY22JLX01301
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：77
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、イオパミドールAPIのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にイオパミドールAPIの世界市場のxxx％を占める「原薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
イオパミドールAPIの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのイオパミドールAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

イオパミドールAPIのグローバル主要企業には、Bracco Imaging、Stellite、Stelliteなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

イオパミドールAPI市場は、種類と用途によって区分されます。世界のイオパミドールAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
原薬、ジェネリック医薬品

【用途別セグメント】
病院、クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- イオパミドールAPI製品概要
- 種類別市場（原薬、ジェネリック医薬品）
- 用途別市場（病院、クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界のイオパミドールAPI販売量予測2017-2028
- 世界のイオパミドールAPI売上予測2017-2028
- イオパミドールAPIの地域別販売量
- イオパミドールAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別イオパミドールAPI販売量
- 主要メーカー別イオパミドールAPI売上
- 主要メーカー別イオパミドールAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（原薬、ジェネリック医薬品）
- イオパミドールAPIの種類別販売量
- イオパミドールAPIの種類別売上
- イオパミドールAPIの種類別価格
・用途別市場規模（病院、クリニック）
- イオパミドールAPIの用途別販売量
- イオパミドールAPIの用途別売上
- イオパミドールAPIの用途別価格
・北米市場
- 北米のイオパミドールAPI市場規模（種類別、用途別）
- 主要国別のイオパミドールAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのイオパミドールAPI市場規模（種類別、用途別）
- 主要国別のイオパミドールAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のイオパミドールAPI市場規模（種類別、用途別）
- 主要国別のイオパミドールAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のイオパミドールAPI市場規模（種類別、用途別）
- 主要国別のイオパミドールAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのイオパミドールAPI市場規模（種類別、用途別）
- 主要国別のイオパミドールAPI市場規模（トルコ、サウジアラビア）
・企業情報
Bracco Imaging、Stellite、Stellite
・産業チェーン及び販売チャネル分析
- イオパミドールAPIの産業チェーン分析
- イオパミドールAPIの原材料
- イオパミドールAPIの生産プロセス
- イオパミドールAPIの販売及びマーケティング
- イオパミドールAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- イオパミドールAPIの産業動向
- イオパミドールAPIのマーケットドライバー
- イオパミドールAPIの課題
- イオパミドールAPIの阻害要因
・主な調査結果

Iopamidol, also known as iodopeptidol, iodopentanol, iopamidol, iopamidol, iopamido, iopamisone, is a non-ionic water-soluble contrast agent, which is a drug for imaging diagnosis.
Market Analysis and Insights: Global Iopamidol API Market
Due to the COVID-19 pandemic, the global Iopamidol API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Original Drug accounting for % of the Iopamidol API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Iopamidol API market size is valued at US$ million in 2021, while the US and Europe Iopamidol API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Iopamidol API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Iopamidol API include Bracco Imaging, Stellite and Stellite, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Iopamidol API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Iopamidol API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Iopamidol API Scope and Segment
Iopamidol API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Iopamidol API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
By Company
Bracco Imaging
Stellite
Stellite
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Iopamidol API Product Introduction
1.2 Market by Type
1.2.1 Global Iopamidol API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Iopamidol API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Iopamidol API Production
2.1 Global Iopamidol API Production Capacity (2017-2028)
2.2 Global Iopamidol API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Iopamidol API Production by Region
2.3.1 Global Iopamidol API Historic Production by Region (2017-2022)
2.3.2 Global Iopamidol API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Iopamidol API Sales in Volume & Value Estimates and Forecasts
3.1 Global Iopamidol API Sales Estimates and Forecasts 2017-2028
3.2 Global Iopamidol API Revenue Estimates and Forecasts 2017-2028
3.3 Global Iopamidol API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Iopamidol API Sales by Region
3.4.1 Global Iopamidol API Sales by Region (2017-2022)
3.4.2 Global Sales Iopamidol API by Region (2023-2028)
3.5 Global Iopamidol API Revenue by Region
3.5.1 Global Iopamidol API Revenue by Region (2017-2022)
3.5.2 Global Iopamidol API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Iopamidol API Production Capacity by Manufacturers
4.2 Global Iopamidol API Sales by Manufacturers
4.2.1 Global Iopamidol API Sales by Manufacturers (2017-2022)
4.2.2 Global Iopamidol API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Iopamidol API in 2021
4.3 Global Iopamidol API Revenue by Manufacturers
4.3.1 Global Iopamidol API Revenue by Manufacturers (2017-2022)
4.3.2 Global Iopamidol API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Iopamidol API Revenue in 2021
4.4 Global Iopamidol API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Iopamidol API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Iopamidol API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Iopamidol API Sales by Type
5.1.1 Global Iopamidol API Historical Sales by Type (2017-2022)
5.1.2 Global Iopamidol API Forecasted Sales by Type (2023-2028)
5.1.3 Global Iopamidol API Sales Market Share by Type (2017-2028)
5.2 Global Iopamidol API Revenue by Type
5.2.1 Global Iopamidol API Historical Revenue by Type (2017-2022)
5.2.2 Global Iopamidol API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Iopamidol API Revenue Market Share by Type (2017-2028)
5.3 Global Iopamidol API Price by Type
5.3.1 Global Iopamidol API Price by Type (2017-2022)
5.3.2 Global Iopamidol API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Iopamidol API Sales by Application
6.1.1 Global Iopamidol API Historical Sales by Application (2017-2022)
6.1.2 Global Iopamidol API Forecasted Sales by Application (2023-2028)
6.1.3 Global Iopamidol API Sales Market Share by Application (2017-2028)
6.2 Global Iopamidol API Revenue by Application
6.2.1 Global Iopamidol API Historical Revenue by Application (2017-2022)
6.2.2 Global Iopamidol API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Iopamidol API Revenue Market Share by Application (2017-2028)
6.3 Global Iopamidol API Price by Application
6.3.1 Global Iopamidol API Price by Application (2017-2022)
6.3.2 Global Iopamidol API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Iopamidol API Market Size by Type
7.1.1 North America Iopamidol API Sales by Type (2017-2028)
7.1.2 North America Iopamidol API Revenue by Type (2017-2028)
7.2 North America Iopamidol API Market Size by Application
7.2.1 North America Iopamidol API Sales by Application (2017-2028)
7.2.2 North America Iopamidol API Revenue by Application (2017-2028)
7.3 North America Iopamidol API Sales by Country
7.3.1 North America Iopamidol API Sales by Country (2017-2028)
7.3.2 North America Iopamidol API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Iopamidol API Market Size by Type
8.1.1 Europe Iopamidol API Sales by Type (2017-2028)
8.1.2 Europe Iopamidol API Revenue by Type (2017-2028)
8.2 Europe Iopamidol API Market Size by Application
8.2.1 Europe Iopamidol API Sales by Application (2017-2028)
8.2.2 Europe Iopamidol API Revenue by Application (2017-2028)
8.3 Europe Iopamidol API Sales by Country
8.3.1 Europe Iopamidol API Sales by Country (2017-2028)
8.3.2 Europe Iopamidol API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Iopamidol API Market Size by Type
9.1.1 Asia Pacific Iopamidol API Sales by Type (2017-2028)
9.1.2 Asia Pacific Iopamidol API Revenue by Type (2017-2028)
9.2 Asia Pacific Iopamidol API Market Size by Application
9.2.1 Asia Pacific Iopamidol API Sales by Application (2017-2028)
9.2.2 Asia Pacific Iopamidol API Revenue by Application (2017-2028)
9.3 Asia Pacific Iopamidol API Sales by Region
9.3.1 Asia Pacific Iopamidol API Sales by Region (2017-2028)
9.3.2 Asia Pacific Iopamidol API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Iopamidol API Market Size by Type
10.1.1 Latin America Iopamidol API Sales by Type (2017-2028)
10.1.2 Latin America Iopamidol API Revenue by Type (2017-2028)
10.2 Latin America Iopamidol API Market Size by Application
10.2.1 Latin America Iopamidol API Sales by Application (2017-2028)
10.2.2 Latin America Iopamidol API Revenue by Application (2017-2028)
10.3 Latin America Iopamidol API Sales by Country
10.3.1 Latin America Iopamidol API Sales by Country (2017-2028)
10.3.2 Latin America Iopamidol API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Iopamidol API Market Size by Type
11.1.1 Middle East and Africa Iopamidol API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Iopamidol API Revenue by Type (2017-2028)
11.2 Middle East and Africa Iopamidol API Market Size by Application
11.2.1 Middle East and Africa Iopamidol API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Iopamidol API Revenue by Application (2017-2028)
11.3 Middle East and Africa Iopamidol API Sales by Country
11.3.1 Middle East and Africa Iopamidol API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Iopamidol API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Overview
12.1.3 Bracco Imaging Iopamidol API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Bracco Imaging Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Bracco Imaging Recent Developments
12.2 Stellite
12.2.1 Stellite Corporation Information
12.2.2 Stellite Overview
12.2.3 Stellite Iopamidol API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Stellite Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Stellite Recent Developments
12.3 Stellite
12.3.1 Stellite Corporation Information
12.3.2 Stellite Overview
12.3.3 Stellite Iopamidol API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Stellite Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Stellite Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Iopamidol API Industry Chain Analysis
13.2 Iopamidol API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Iopamidol API Production Mode & Process
13.4 Iopamidol API Sales and Marketing
13.4.1 Iopamidol API Sales Channels
13.4.2 Iopamidol API Distributors
13.5 Iopamidol API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Iopamidol API Industry Trends
14.2 Iopamidol API Market Drivers
14.3 Iopamidol API Market Challenges
14.4 Iopamidol API Market Restraints
15 Key Finding in The Global Iopamidol API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Iopamidol API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Original Drug
Table 3. Major Manufacturers of Generic Drug
Table 4. Global Iopamidol API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Iopamidol API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Iopamidol API Production by Region (2017-2022) & (Tons)
Table 7. Global Iopamidol API Production Market Share by Region (2017-2022)
Table 8. Global Iopamidol API Production by Region (2023-2028) & (Tons)
Table 9. Global Iopamidol API Production Market Share by Region (2023-2028)
Table 10. Global Iopamidol API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Iopamidol API Sales by Region (2017-2022) & (Tons)
Table 12. Global Iopamidol API Sales Market Share by Region (2017-2022)
Table 13. Global Iopamidol API Sales by Region (2023-2028) & (Tons)
Table 14. Global Iopamidol API Sales Market Share by Region (2023-2028)
Table 15. Global Iopamidol API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Iopamidol API Revenue Market Share by Region (2017-2022)
Table 17. Global Iopamidol API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Iopamidol API Revenue Market Share by Region (2023-2028)
Table 19. Global Iopamidol API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Iopamidol API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Iopamidol API Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Iopamidol API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Iopamidol API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Iopamidol API Revenue Share by Manufacturers (2017-2022)
Table 25. Iopamidol API Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Iopamidol API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Iopamidol API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iopamidol API as of 2021)
Table 28. Iopamidol API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Iopamidol API Product Offered
Table 30. Date of Manufacturers Enter into Iopamidol API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 33. Global Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 34. Global Iopamidol API Sales Share by Type (2017-2022)
Table 35. Global Iopamidol API Sales Share by Type (2023-2028)
Table 36. Global Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Iopamidol API Revenue Share by Type (2017-2022)
Table 39. Global Iopamidol API Revenue Share by Type (2023-2028)
Table 40. Iopamidol API Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Iopamidol API Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 43. Global Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 44. Global Iopamidol API Sales Share by Application (2017-2022)
Table 45. Global Iopamidol API Sales Share by Application (2023-2028)
Table 46. Global Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Iopamidol API Revenue Share by Application (2017-2022)
Table 49. Global Iopamidol API Revenue Share by Application (2023-2028)
Table 50. Iopamidol API Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Iopamidol API Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 53. North America Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 54. North America Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 57. North America Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 58. North America Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Iopamidol API Sales by Country (2017-2022) & (Tons)
Table 61. North America Iopamidol API Sales by Country (2023-2028) & (Tons)
Table 62. North America Iopamidol API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Iopamidol API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 65. Europe Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 66. Europe Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 69. Europe Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 70. Europe Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Iopamidol API Sales by Country (2017-2022) & (Tons)
Table 73. Europe Iopamidol API Sales by Country (2023-2028) & (Tons)
Table 74. Europe Iopamidol API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Iopamidol API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Iopamidol API Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Iopamidol API Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Iopamidol API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Iopamidol API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Iopamidol API Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Iopamidol API Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Iopamidol API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Iopamidol API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Iopamidol API Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Iopamidol API Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Iopamidol API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Iopamidol API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Iopamidol API Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Iopamidol API Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Iopamidol API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Iopamidol API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Iopamidol API Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Iopamidol API Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Iopamidol API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Iopamidol API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Bracco Imaging Corporation Information
Table 113. Bracco Imaging Description and Major Businesses
Table 114. Bracco Imaging Iopamidol API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Bracco Imaging Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bracco Imaging Recent Development
Table 117. Stellite Corporation Information
Table 118. Stellite Description and Major Businesses
Table 119. Stellite Iopamidol API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Stellite Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Stellite Recent Development
Table 122. Stellite Corporation Information
Table 123. Stellite Description and Major Businesses
Table 124. Stellite Iopamidol API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Stellite Iopamidol API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Stellite Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Iopamidol API Distributors List
Table 130. Iopamidol API Customers List
Table 131. Iopamidol API Market Trends
Table 132. Iopamidol API Market Drivers
Table 133. Iopamidol API Market Challenges
Table 134. Iopamidol API Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Iopamidol API Product Picture
Figure 2. Global Iopamidol API Market Share by Type in 2021 & 2028
Figure 3. Original Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Iopamidol API Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Iopamidol API Report Years Considered
Figure 9. Global Iopamidol API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 10. Global Iopamidol API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Iopamidol API Production Market Share by Region (2017-2022)
Figure 12. Global Iopamidol API Production Market Share by Region (2023-2028)
Figure 13. Iopamidol API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 14. Iopamidol API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 15. Iopamidol API Production Growth Rate in China (2017-2028) & (Tons)
Figure 16. Iopamidol API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 17. Global Iopamidol API Sales 2017-2028 (Tons)
Figure 18. Global Iopamidol API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Iopamidol API Revenue 2017-2028 (US$ Million)
Figure 20. Global Iopamidol API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Iopamidol API Sales Market Share by Region (2017-2022)
Figure 22. Global Iopamidol API Sales Market Share by Region (2023-2028)
Figure 23. North America Iopamidol API Sales YoY (2017-2028) & (Tons)
Figure 24. North America Iopamidol API Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Iopamidol API Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Iopamidol API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Iopamidol API Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Iopamidol API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Iopamidol API Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Iopamidol API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Iopamidol API Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Iopamidol API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Iopamidol API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Iopamidol API in the World: Market Share by Iopamidol API Revenue in 2021
Figure 35. Iopamidol API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Iopamidol API Sales Market Share by Type (2017-2028)
Figure 37. Global Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 38. Global Iopamidol API Sales Market Share by Application (2017-2028)
Figure 39. Global Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 40. North America Iopamidol API Sales Market Share by Type (2017-2028)
Figure 41. North America Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 42. North America Iopamidol API Sales Market Share by Application (2017-2028)
Figure 43. North America Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 44. North America Iopamidol API Sales Share by Country (2017-2028)
Figure 45. North America Iopamidol API Revenue Share by Country (2017-2028)
Figure 46. United States Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Iopamidol API Sales Market Share by Type (2017-2028)
Figure 49. Europe Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 50. Europe Iopamidol API Sales Market Share by Application (2017-2028)
Figure 51. Europe Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 52. Europe Iopamidol API Sales Share by Country (2017-2028)
Figure 53. Europe Iopamidol API Revenue Share by Country (2017-2028)
Figure 54. Germany Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 55. France Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Iopamidol API Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Iopamidol API Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Iopamidol API Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Iopamidol API Revenue Share by Region (2017-2028)
Figure 65. China Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 68. India Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Iopamidol API Sales Market Share by Type (2017-2028)
Figure 75. Latin America Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Iopamidol API Sales Market Share by Application (2017-2028)
Figure 77. Latin America Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Iopamidol API Sales Share by Country (2017-2028)
Figure 79. Latin America Iopamidol API Revenue Share by Country (2017-2028)
Figure 80. Mexico Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 83. Colombia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Iopamidol API Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Iopamidol API Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Iopamidol API Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Iopamidol API Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Iopamidol API Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Iopamidol API Revenue Share by Country (2017-2028)
Figure 90. Turkey Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Iopamidol API Revenue (2017-2028) & (US$ Million)
Figure 93. Iopamidol API Value Chain
Figure 94. Iopamidol API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed


★調査レポート[イオパミドールAPIの世界市場インサイト・予測（～2028年）] (コード：QY22JLX01301)販売に関する免責事項を必ずご確認ください。
★調査レポート[イオパミドールAPIの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 造影剤APIの世界市場インサイト・予測（～2028年）
  • ヨード造影剤中間体の世界市場インサイト・予測（～2028年）
  • 有機ヨウ化物造影剤の世界市場インサイト・予測（～2028年）
  • 5-アミノ-2,4,6-トリヨードイソフタロイルジクロリドのグローバル市場2023年：イオパミドール原薬、ラバーソール原薬、その他
  • イオベルソールAPIの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆